Breast Cancer Trial, Not Yet Recruiting NCT07657442 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07657442
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People with a general health and activity level rated as good to fully active (scored 0 to 2 on a standard medical scale).
  • People who have had their breast cancer confirmed by laboratory testing, including invasive breast cancer or a type of early-stage cancer found in the milk ducts (ductal carcinoma in situ).
  • People whose cancer was at an early stage, with a tumour of limited size and no spread to nearby lymph nodes or other parts of the body at the time of diagnosis.
  • People who have had breast-conserving surgery (an operation that removes the tumour but keeps most of the breast).
  • People whose surgery results showed that the edges of the removed tissue were clear of cancer cells, with a margin of more than 2 mm.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cancer has spread to the lymph nodes in the surrounding region.
  • People whose cancer has spread to other parts of the body.
  • People who have cancer in both breasts.
  • People who have previously had radiotherapy to the chest area.
  • People whose life expectancy is estimated to be less than 5 years.
  • People who are currently breastfeeding or pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8610-87788803

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
15 June 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Local recurrence rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov